Literature DB >> 8060550

The changing spectrum of AIDS index diseases in Canada.

J S Montaner1, T Le, R Hogg, M Ricketts, D Sutherland, S A Strathdee, M O'Shaughnessy, M T Schechter.   

Abstract

OBJECTIVE: To describe the changing spectrum of AIDS index diseases in Canada over a 10-year period from 1981 to 1991.
DESIGN: A descriptive, population-based study.
SETTING: Canada. PATIENTS: All cases of AIDS in Canada reported by the Division of HIV/AIDS Epidemiology of the Department of National Health and Welfare. MAIN OUTCOME MEASURES: Age-standardized rates of initial AIDS manifestations (1987 Centers for Disease Control and Prevention case definition), by year of diagnosis among adults in Canada.
RESULTS: A total of 6641 adult AIDS cases were examined. The rate of Pneumocystis carinii pneumonia (PCP) peaked in 1989 with a rate of 3.18 per 100,000, declining to 2.74 per 100,000 in 1991 (P = 0.894). Similarly, the rate of Kaposi's sarcoma (KS) stabilized during this interval from 1.06 per 100,000 in 1987 to 1.14 per 100,000 in 1991 (P = 0.189). In contrast, the rates of all other AIDS-defining illnesses increased from 1.48 per 100,000 in 1987 to 3.43 per 100,000 in 1991 (P = 0.001). For these other AIDS index diseases, significant rate increases were observed for esophageal candidiasis, cytomegalovirus (CMV) diseases, wasting syndrome, toxoplasmosis, and Mycobacterium avium complex (MAC) disease.
CONCLUSIONS: Our study shows a leveling and decline in incidence of KS and PCP, respectively, and a concomitant increase of other diagnoses, especially esophageal candidiasis, CMV, wasting syndrome, toxoplasmosis, and MAC disease in Canada. These findings highlight the importance of developing specific strategies to prevent emerging AIDS index diseases and serve as a cautionary note to practicing clinicians, indicating the relative widening of the spectrum of HIV index diseases.

Entities:  

Mesh:

Year:  1994        PMID: 8060550     DOI: 10.1097/00002030-199405000-00018

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

Authors:  V Soriano; J García-Samaniego; E Valencia; R Rodríguez-Rosado; F Muñoz; J González-Lahoz
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

2.  The probability of acquiring primary Toxoplasma infection in HIV-infected patients: results of an 8-year retrospective study.

Authors:  I Reiter-Owona; R Bialek; J K Rockstroh; H M Seitz
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

3.  Trends of Kaposi's sarcoma at AIDS diagnosis in Europe and the United States, 1987-94.

Authors:  S Franceschi; L Dal Maso; A Lo Re; D Serraino; C La Vecchia
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of 236 autopsied cases in mumbai, India.

Authors:  Dhaneshwar Namdeorao Lanjewar
Journal:  Patholog Res Int       Date:  2011-05-23

5.  Toxoplasma gondii LCAT Primarily Contributes to Tachyzoite Egress.

Authors:  Aric J Schultz; Vern B Carruthers
Journal:  mSphere       Date:  2018-02-28       Impact factor: 4.389

6.  Identifying factors associated with changes in CD4(+) count in HIV-infected adults in Saskatoon, Saskatchewan.

Authors:  Kelsey Hunt; Prosanta Mondal; Stephanie Konrad; Stuart Skinner; Kali Gartner; Hyun J Lim
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jul-Aug       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.